BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $1.51B
1-Year Est. Return 95.26%
This Quarter Est. Return
1 Year Est. Return
+95.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.51B
AUM Growth
+$707M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
24
New
Increased
Reduced
Closed

Top Buys

1
+$419M
2
+$49.8M
3
+$6.4M

Top Sells

1
+$110M
2
+$45.9M
3
+$30.9M
4
PHVS icon
Pharvaris
PHVS
+$3.05M
5
IVVD icon
Invivyd
IVVD
+$1.29M

Sector Composition

1 Healthcare 99.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTFL
1
Heartflow Inc
HTFL
$2.44B
$419M 27.81%
+12,448,158
NAMS icon
2
NewAmsterdam Pharma
NAMS
$3.84B
$305M 20.23%
10,719,110
CDTX icon
3
Cidara Therapeutics
CDTX
$6.93B
$289M 19.2%
3,020,990
+520,310
PHVS icon
4
Pharvaris
PHVS
$1.56B
$79.4M 5.27%
3,181,275
-122,106
OLMA icon
5
Olema Pharmaceuticals
OLMA
$2.47B
$67M 4.45%
6,843,954
SVRA icon
6
Savara
SVRA
$1.23B
$62.8M 4.17%
17,600,621
DNTH icon
7
Dianthus Therapeutics
DNTH
$1.79B
$51.8M 3.44%
1,315,892
-1,166,358
SLDB icon
8
Solid Biosciences
SLDB
$411M
$48.8M 3.24%
7,911,669
UPB
9
Upstream Bio Inc
UPB
$1.61B
$45.9M 3.05%
2,439,538
RPID icon
10
Rapid Micro Biosystems
RPID
$148M
$28.2M 1.87%
8,434,560
TNGX icon
11
Tango Therapeutics
TNGX
$1.14B
$22.8M 1.51%
2,712,008
CABA icon
12
Cabaletta Bio
CABA
$232M
$22.6M 1.5%
9,677,125
KYTX icon
13
Kyverna Therapeutics
KYTX
$307M
$20.2M 1.34%
3,368,370
ANNX icon
14
Annexon
ANNX
$718M
$16M 1.06%
5,249,069
XFOR icon
15
X4 Pharmaceuticals
XFOR
$320M
$8.33M 0.55%
2,436,588
+1,872,729
AVIR icon
16
Atea Pharmaceuticals
AVIR
$245M
$7.21M 0.48%
2,485,638
XLO icon
17
Xilio Therapeutics
XLO
$34.1M
$3.85M 0.26%
4,566,817
MRSN icon
18
Mersana Therapeutics
MRSN
$145M
$2.69M 0.18%
346,545
-2
CCCC icon
19
C4 Therapeutics
CCCC
$195M
$2.47M 0.16%
1,111,910
IPSC icon
20
Century Therapeutics
IPSC
$66.7M
$1.76M 0.12%
3,538,609
-1,871,752
NAMSW icon
21
NewAmsterdam Pharma Warrant
NAMSW
$100M
$1.71M 0.11%
100,000
IRON icon
22
Disc Medicine
IRON
$3.41B
– –
-583,500
IVVD icon
23
Invivyd
IVVD
$634M
– –
-1,799,595
NUVL icon
24
Nuvalent
NUVL
$7.88B
– –
-1,447,267